Medizinische Universitätsklinik Bochum

www.medunikkh.de

Efficacy of 6 courses CHOP plus Rituximab Votum-Nr: 2409 Die Studie wurde am 01.06.2010 geschlossen

Efficancy of 6 courses CHOP plus Rituximab followed by myeloablative radiochemotherapy and autologous stemm cell transplantation versus alternating courses of 3x CHOP and 3 X DHAP plus Rituximab followed by a high dose ARA-C containing myeloablative regimen and autologous stemm cell transplantation MCL Younger

Leitung

Prof. Dr. Hiddemann

Ansprechpartner